13F-HR filed by Investors Research Corp
Investors Research Corp filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-07-29, with 1,022 holding rows worth $289,039,000.
- Accession
- 0001062993-21-006799
- Filer
- CIK 1730630
- Filed
- 2021-07-29
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 1,022 entries on the cover page, a total value of $289,039,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $289,039,000 with VALUE read as thousands by filing date, 13F file number 028-18408. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LYRA THERAPEUTICS INC | 55234L105 | COM | 15 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| PROSPECTOR CAPITAL CORP | G7273A113 | *W EXP 01/11/202 | 22 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| SVF INVESTMENT CORP | G8601L128 | *W EXP 01/12/202 | 10 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| COMPUTE HEALTH ACQUISITIN CO | 204833115 | *W EXP 01/25/202 | 12 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| EPIPHANY TECHNOLOGY ACQUISIT | 29429X117 | *W EXP 01/12/202 | 22 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| SVF INVESTMENT CORP | G8601L102 | CL A SHS | 50 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| COMPUTE HEALTH ACQUISITIN CO | 204833107 | COM CL A | 48 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| TIDEWATER INC NEW | 88642R174 | *W EXP 11/14/202 | 632 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| ACE Convergence Acquisition Corp | G0083D120 | COM | 50 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| VPC IMPACT ACQUISITION HLDNG | G9441E100 | SHS CL A | 20 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| LOGICBIO THERAPEUTICS INC | 54142F102 | COM | 89 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| CODIAK BIOSCIENCES INC | 192010106 | COM | 22 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| NIGHTDRAGON ACQUISITION CORP | 65413D105 | CMN | 50 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| CRUCIBLE ACQUISITION CORP | 22877P116 | *W EXP 12/26/202 | 21 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| D8 HOLDINGS CORP | G2614K110 | SHS CL A | 15 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| LIBERTY MEDIA ACQUISITION CO | 53073L112 | *W EXP 99/99/999 | 7 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| NDACW US 31 Dec 27 C11.5 | 65413D113 | *W EXP 02/26/202 | 10 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| COLICITY INC | 194170106 | COM CL A | 50 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| SALARIUS PHARMACEUTICALS INC | 79400X107 | COM NEW | 11 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| COLICITY INC | 194170114 | *W EXP 02/24/202 | 10 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| APEXIGEN INC | 11374E104 | COM | 15 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| BROOKLINE CAP ACQUISITION CO | 11374E112 | *W EXP 08/31/202 | 7 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001062993-21-006799 | this filing | 2021-07-29 | acceptance time not in the bulk data set |